Advertisement
Video ThumbnailVideo Thumbnail
Updated: Dec 28, 2019, 03:10 PM IST

Scientists find Tuberculosis vaccine lowers rate of Alzheimers in cancer patients

Currently, Alzheimer's affects one-in-ten adults over the age of 65, number that is expected to triple by 2030. The need to find a cure is great. In the backdrop of the following facts, researchers have developed a TB vaccine that lowers rates of Alzheimer's disease in cancer patients. Now there may be a glimmer of hope. A research team headed by Herve Bercovier, Charles Greenblatt and Benjamin Klein at the Hebrew University of Jerusalem (HU)'s Department of Microbiology and Molecular Genetics has discovered that the Bacillus Calmette-Guerin (BCG) vaccine, originally developed for tuberculosis and commonly used to treat bladder cancer, may also be an effective treatment to prevent Alzheimer's. The study was published in the journal PLOS ONE.

Advertisement

Currently, Alzheimer's affects one-in-ten adults over the age of 65, number that is expected to triple by 2030. The need to find a cure is great. In the backdrop of the following facts, researchers have developed a TB vaccine that lowers rates of Alzheimer's disease in cancer patients. Now there may be a glimmer of hope. A research team headed by Herve Bercovier, Charles Greenblatt and Benjamin Klein at the Hebrew University of Jerusalem (HU)'s Department of Microbiology and Molecular Genetics has discovered that the Bacillus Calmette-Guerin (BCG) vaccine, originally developed for tuberculosis and commonly used to treat bladder cancer, may also be an effective treatment to prevent Alzheimer's. The study was published in the journal PLOS ONE.

Read More
Advertisement
Advertisement
Advertisement